Generics - North America, Markets & Marketing


Popular Filters

1 to 25 of 89 results

Prasco to market the authorized generic of Lilly’s Evista in USA


Privately-held US generics firm Prasco has signed a further deal with US pharma major Eli Lilly to market…

Anti-Arthritics/RheumaticsEli LillyEvistaGenericsMarkets & MarketingNorth AmericaPrasco LaboratoriesUSA

Lupin launches generic Niaspan in USA


Indian drugmaker Lupin says that its US subsidiary has launched its niacin extended-release tablets USP,…

AbbVieCardio-vascularGenericsLupinMarkets & MarketingNiaspanNorth AmericaUSA

Generic drugs slow pharma spending growth in Canada

Generic drugs slow pharma spending growth in Canada


Last year, C$29.3 billion ($26.47 billion) was spent on prescription drugs in Canada, but the annual…

CanadaFinancialGenericsMarkets & MarketingNorth AmericaPharmaceutical

Amneal debuts generic Esomeprazole strontium in USA


Privately-held US generics drugmaker Amneal Pharmaceuticals has announced the launch of generic esomeprazole…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumGastro-intestinalsGenericsMarkets & MarketingNexiumNorth AmericaUSA

Teva launches authorized generic of Detrol in USA

Teva launches authorized generic of Detrol in USA


Israel’s Teva Pharmaceutical Industries, the world’s largest generic drugmaker, says it has launched…

Detrol LAGenericsGenito-urinaryMarkets & MarketingNorth AmericaPfizerTeva Pharmaceutical IndustriesUSA

US FTC rescheduled workshop on state regulations and naming conventions set for February


The US Federal Trade Commission announced its one-day public workshop on competition and follow-on biologics,…

BiosimilarsGenericsMarkets & MarketingNorth AmericaRegulationUSA

Teva updates on Lonquex and Granix launches

Teva updates on Lonquex and Granix launches


Israel-based Teva Pharmaceutical Industries announced two significant additions to its global oncology…

balugrastimBiosimilarsEuropeGenericsLonquexMarkets & MarketingNorth AmericaOncologyRegulationTeva Pharmaceutical Industries

Mylan launches first generic Focalin XR capsules

Mylan launches first generic Focalin XR capsules


US generics major Mylan has launched dexmethylphenidate hydrochloride extended-release (ER) capsules,…

Focalin XRGenericsMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaNovartis

FDA takes action to speed safety information updates on generic drugs

FDA takes action to speed safety information updates on generic drugs


A proposed US Food and Drug Administration rule would speed the dissemination of new safety information…

GenericsMarkets & MarketingNorth AmericaRegulation

Mylan launches first generic of Pfizer antifungal

Mylan launches first generic of Pfizer antifungal


Mylan says it has launched voriconazole for oral suspension, which is the first generic version of Pfizer's…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPfizerVfend

Roche/Chugai's bitopertin set to garner $1.5 billion sales in 2022


Swiss drug major Roche (ROG: SIX) and its majority-owned Japanese affiliate Chugai's glycine transporter-1…

AbilifyAbilify MaintenabitopertinChugai PharmaceuticalEuropeGenericsJanssenLundbeckMarkets & MarketingNeurologicalNorth AmericaOtsukaPaliperidonePharmaceuticalRocheSeroquelZyprexa

Generic Temodar launches in USA


Israel-headquartered Teva Pharmaceutical Industries (NYSE: TEVA) and Perrigo (NYSE: PRGO;TASE) today…

GenericsMarkets & MarketingMerck & CoNorth AmericaOncologyPerrigoTemodarTeva Pharmaceutical Industries

Actavis debuts new formulations of Fioricet


US generics major Actavis (NYSE: ACT) has launched new formulations of Fioricet (butalbital, acetaminophen…

AcetaminophenActavisFioricetFioricet with CodeineGenericsMarkets & MarketingNeurologicalNorth AmericaPharmaceutical

US FTC will continue to challenge "anticompetitive" pharma pay-for-delay deals


The Federal Trade Commission told a Senate Judiciary subcommittee yesterday (July 23) that it will continue…

GenericsLegalLicensingMarkets & MarketingNorth AmericaPharmaceutical

Generic versions of Trilipix debut in USA; Mylan sued by UCB


Impax Laboratories (Nasdaq: IPXL) today announced yesterday (July 15) that it is commencing shipment…

AbbVieCardio-vascularGenericsImpax LaboratoriesLegalMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaPatentsTripilixUCBVimpat

Generic launches by Mylan, Stada Arz and Dr Reddy's


US copy drugs maker Mylan (NYSE: MYL) has launched norethindrone tablets USP, 0.35 the generic version…

Dr Reddy's LaboratoriesEuropeGenericsLamictal XRMarkets & MarketingMen's HealthMicronorMylan LaboratoriesNeurologicalNorth AmericaReproductiveSTADA ArzneimittelViagra

New Public Citizen report highlights need to allow generic drugmakers to update labeling as they learn of new risks


Many potential hazards are not discovered until years after drugs have been on the market, a new Public…

GenericsMarkets & MarketingNorth AmericaRegulation

Sagent Pharma expands voluntary withdrawal of vecuronium inj vials


US drugmaker Sagent Pharmaceuticals (Nasdaq: SGNT) said today (June 13) that it is expanding its voluntary…

GenericsMarkets & MarketingMustafa Nevzat PharmaNeurologicalNorth AmericaSagent Pharmaceuticalsvecuronium bromide

New Florida law takes a major step in promoting access to biologic medicines


Legislation amending the US state of Florida's existing prescription drug substitution law has the potential…

BiotechnologyGenericsLegalMarkets & MarketingNorth AmericaRegulation

US Appeals Court puts temporary stop on sales of generics of AstraZeneca's Pulmicort Respules


Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced last Friday (May 24) that the US Court of Appeals…

ActavisAstraZenecaGenericsLegalMarkets & MarketingNorth AmericaPharmaceuticalPulmicort RespulesRespiratory and Pulmonary

Impax launches authorized generic of Zomig, as Mylan debuts copy of Tricor in USA


US drugmaker Impax Laboratories (Nasdaq: IPXL) says that its generics division, Global Pharmaceuticals,…

AbbVieAstraZenecaCardio-vascularGenericsImpax LaboratoriesMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaTricorZomig

US FDA approves Lupin's generic version of Teva's Seasonique and Taro's Topicort


Indian drugmaker Lupin (BSE: 500257) saw its shares gain 2.3% to 659.65 rupees by close of trading on…

DayseeDermatologicalsGenericsLupinMarkets & MarketingNorth AmericaPharmaceuticalRegulationReproductiveSeasoniqueTaro PharmaceuticalsTeva Pharmaceutical IndustriesTopicort

Actavis settles with Valeant to launch generic Ziana and Zyclara in USA


US generics drug major Actavis (NYSE: ACT) has reached settlement agreements with Medicis Pharmaceutical,…

ActavisGenericsMarkets & MarketingNorth AmericaPatentsValeant PharmaceuticalsZiana GelZyclara

US pulmonologists view refractory asthma patient treatment with biosimilar Xolair by end-2018


US pulmonologists surveyed by health care advisory firm Decision Resources estimate that only 19% percent…

BiotechnologyBoehringer IngelheimGenentechGenericsMarkets & MarketingNorth AmericaNovartisPfizerRespiratory and PulmonarySpirivaXolair

1 to 25 of 89 results

Back to top